| For: | Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol 2021; 27(46): 7925-7942 [PMID: 35046621 DOI: 10.3748/wjg.v27.i46.7925] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i46/7925.htm |
| Number | Citing Articles |
| 1 |
Kaustuv Mandal, Suman Halder, Pulakesh Roy, Manash K. Paul, Sipra Das Bit, Rajib Banerjee. An Online Mobility Management System to Automatically Avoid Road Blockage and COVID-19 Hotspots. New Generation Computing 2022; 40(4): 1203 doi: 10.1007/s00354-022-00180-4
|
| 2 |
Efthymios P Tsounis, Christos Triantos, Christos Konstantakis, Markos Marangos, Stelios F Assimakopoulos. Intestinal barrier dysfunction as a key driver of severe COVID-19. World Journal of Virology 2023; 12(2): 68-90 doi: 10.5501/wjv.v12.i2.68
|
| 3 |
Claudio Alba, Marta Mozota, Rebeca Arroyo, Natalia Gómez-Torres, Irma Castro, Juan Miguel Rodríguez. Influence of SARS-CoV-2 Status and Aging on the Nasal and Fecal Immunological Profiles of Elderly Individuals Living in Nursing Homes. Viruses 2023; 15(6): 1404 doi: 10.3390/v15061404
|
| 4 |
Acute gastrointestinal and post-acute COVID-19 gastrointestinal syndrome assessment on the Gastrointestinal Symptom Rating Scale scoring system: A questionnaire-based survey. Journal of Family Medicine and Primary Care 2024; 13(12): 5787 doi: 10.4103/jfmpc.jfmpc_707_24
|
| 5 |
Eakkawit Yamasmith, Jennifer D. Kinslow, Michael G. Berg, Gavin A. Cloherty, James N. Moy, Alan L. Landay, Yupin Suputtamongkol, Wiwit Tantibhedhyangkul. Role of biomarkers in predicting disease severity in acute dengue and SARs-CoV-2-Infected patients. BMC Infectious Diseases 2025; doi: 10.1186/s12879-025-12196-4
|
| 6 |
Marina Bambi, Heidi C. Hauffe, Claudia Barelli. Associations and interactions between prokaryotes and other gut biota in non-human primates. Primates 2025; doi: 10.1007/s10329-025-01224-1
|
| 7 |
Chinmaya Mahapatra, Sakshi Jadhav, Prasoon Kumar, Dijendra Nath Roy, Awanish Kumar, Manash K. Paul. Potential activity of nanomaterials to combat SARS-CoV-2 and mucormycosis coinfection. Expert Review of Anti-infective Therapy 2024; 22(12): 1143 doi: 10.1080/14787210.2024.2423359
|
| 8 |
D. I. Trukhan. Disorders of intestinal microbiocenosis: expanding the application of probiotics. Meditsinskiy sovet = Medical Council 2022; (7): 132 doi: 10.21518/2079-701X-2022-16-7-132-143
|
| 9 |
Prabhat K. Purbey, Koushik Roy, Sandeep Gupta, Manash K. Paul. Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2. Molecular Immunology 2023; 156: 111 doi: 10.1016/j.molimm.2023.03.009
|
| 10 |
A. Satyanarayan Naidu, Fereidoon Shahidi, Chin-Kun Wang, Kenji Sato, Aman Wirakartakusumah, Ogugua C. Aworh, Roger A. Clemens. SARS-CoV-2-induced host metabolic reprogram (HMR): nutritional interventions for global management of COVID-19 and post-acute sequelae of COVID-19 (PASC). Journal of Food Bioactives 2022; : 1 doi: 10.31665/JFB.2022.18306
|
| 11 |
Laure-Alix Clerbaux, Sally A. Mayasich, Amalia Muñoz, Helena Soares, Mauro Petrillo, Maria Cristina Albertini, Nicolas Lanthier, Lucia Grenga, Maria-Joao Amorim. Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. Journal of Clinical Medicine 2022; 11(19): 5691 doi: 10.3390/jcm11195691
|
| 12 |
Alejandro Jiménez-Meléndez, Ruchika Shakya, Turhan Markussen, Lucy J. Robertson, Mette Myrmel, Shokouh Makvandi-Nejad. Gene expression profile of HCT-8 cells following single or co-infections with Cryptosporidium parvum and bovine coronavirus. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-49488-1
|
| 13 |
Carlo Brogna, Valentina Viduto, Mark Fabrowski, Simone Cristoni, Giuliano Marino, Luigi Montano, Marina Piscopo. The importance of the gut microbiome in the pathogenesis and transmission of SARS-CoV-2. Gut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2244718
|
| 14 |
Martina Grot, Karolina Krupa-Kotara, Agata Wypych-Ślusarska, Mateusz Grajek, Agnieszka Białek-Dratwa. The Concept of Intrauterine Programming and the Development of the Neonatal Microbiome in the Prevention of SARS-CoV-2 Infection. Nutrients 2022; 14(9): 1702 doi: 10.3390/nu14091702
|
| 15 |
A. Satyanarayan Naidu, Chin-Kun Wang, Pingfan Rao, Fabrizio Mancini, Roger A. Clemens, Aman Wirakartakusumah, Hui-Fang Chiu, Chi-Hua Yen, Sebastiano Porretta, Issac Mathai, Sreus A. G. Naidu. Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID. npj Science of Food 2024; 8(1) doi: 10.1038/s41538-024-00261-2
|
| 16 |
Qi Chen, Qin Chen. Research trends of intestinal barrier in ulcerative colitis: a bibliometric analysis. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1657620
|
| 17 |
Philipp E Scherer, John P Kirwan, Clifford J Rosen. Post-acute sequelae of COVID-19: A metabolic perspective. eLife 2022; 11 doi: 10.7554/eLife.78200
|
| 18 |
Samson Afewerki, Thiago Domingues Stocco, André Diniz Rosa da Silva, André Sales Aguiar Furtado, Gustavo Fernandes de Sousa, Guillermo U. Ruiz-Esparza, Thomas J. Webster, Fernanda R. Marciano, Maria Strømme, Yu Shrike Zhang, Anderson Oliveira Lobo. In vitro high-content tissue models to address precision medicine challenges. Molecular Aspects of Medicine 2023; 91: 101108 doi: 10.1016/j.mam.2022.101108
|
| 19 |
Siva Sundara Kumar Durairajan, Abhay Kumar Singh, Udhaya Bharathy Saravanan, Mayurikaa Namachivayam, Moorthi Radhakrishnan, Jian-Dong Huang, Rahul Dhodapkar, Hongjie Zhang. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications. Viruses 2023; 15(6): 1231 doi: 10.3390/v15061231
|
| 20 |
Kaplana Mandal, Shalaka Wahane, Muhammad Nihad, Anubhab Mukherjee, Bharti Bisht, Chrianjay Mukhopadhyay, Bipasha Bose, Manash K. Paul. Organoid Technology: Disease Modelling, Drug Discovery, and Personalized Medicine. 2025; : 1 doi: 10.2174/9789815238693125010003
|
| 21 |
Qiong Wang, Feng Gao, Di Zhu, Hongyan Ren, Yakun Xu, Mengmeng Lou, Chunjie Fei, Xin Xu, Zujiang Yu, Zhigang Ren. Alterations in the oral microbiome detected during long-term follow-up of COVID-19 recovered patients. Journal of Infection and Public Health 2025; 18(12): 102983 doi: 10.1016/j.jiph.2025.102983
|
| 22 |
Stelios F. Assimakopoulos, Gerasimos Eleftheriotis, Maria Lagadinou, Vassilios Karamouzos, Periklis Dousdampanis, Georgios Siakallis, Markos Marangos. SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction. Microorganisms 2022; 10(5): 1050 doi: 10.3390/microorganisms10051050
|
